Bicycle Therapeutics Plc ADR
(BCYC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -198,806 | -139,706 | -60,754 | -169,031 | -117,177 |
| Depreciation Amortization | 5,086 | 3,330 | 1,634 | 7,174 | 5,470 |
| Income taxes - deferred | -1,693 | -1,647 | -1,316 | -5,226 | -4,192 |
| Accounts receivable | N/A | N/A | -133 | N/A | N/A |
| Accounts payable and accrued liabilities | -3,990 | 1,080 | -5,019 | 3,095 | -7,593 |
| Other Working Capital | -66,134 | -42,408 | -36,628 | -37,849 | -72,704 |
| Other Operating Activity | 35,208 | 20,195 | 15,846 | 37,113 | 40,868 |
| Operating Cash Flow | $-230,329 | $-159,156 | $-86,370 | $-164,724 | $-155,328 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,776 | -1,102 | -604 | -1,235 | -867 |
| Investing Cash Flow | $-1,776 | $-1,102 | $-604 | $-1,235 | $-867 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -31,863 | -31,863 |
| Common Stock Issued | 4 | 3 | 2 | 551,655 | 551,410 |
| Other Financing Activity | -120 | -89 | -43 | -42 | 0 |
| Financing Cash Flow | $-116 | $-86 | $-41 | $519,750 | $519,547 |
| Exchange Rate Effect | 1,026 | 2,275 | 468 | -694 | 1,087 |
| Beginning Cash Position | 880,067 | 880,067 | 880,067 | 526,970 | 526,970 |
| End Cash Position | 648,872 | 721,998 | 793,520 | 880,067 | 891,409 |
| Net Cash Flow | $-231,195 | $-158,069 | $-86,547 | $353,097 | $364,439 |
| Free Cash Flow | |||||
| Operating Cash Flow | -230,329 | -159,156 | -86,370 | -164,724 | -155,328 |
| Capital Expenditure | -1,776 | -1,102 | -604 | -1,235 | -867 |
| Free Cash Flow | -232,105 | -160,258 | -86,974 | -165,959 | -156,195 |